Healthcare >> CEO Interviews >> October 9, 2000
STEVEN JAMES LEE has been Chairman and Chief Executive Officer of
PolyMedica Corporation since June 1996. Prior to that, he was President,
Chief Executive Officer and a Director since June 1990. PolyMedica is a
rapidly growing leading national provider of direct-to-consumer
specialty medical products and services. Fortune magazine ranked
PolyMedica as the 30th fastest growing company in America, and it has
recently been included in the S&P 600 and the Russell 2000 and Russell
3000 indices. From 1987 to April 1990, he was President, Chief Executive
Officer and Director of Shawmut National Ventures and was responsible
for the venture capital activities of a $26 billion super-regional
financial services company. Before joining Shawmut, he was President,
Chief Executive Officer and Director of Repligen Corporation, a major
biotechnology company located in Needham, MA, which is developing
vaccines for the AIDS virus. Mr. Lee has also spent 11 years in venture
capital as President of Venture Management Advisors, an offshore venture
capital fund, and at Bankers Trust Company. He is on the Board of
Directors of Kensey Nash Corporation and several privately and publicly
held companies financed through venture capital investments. Mr. Lee has
written six books and numerous articles on various business and
financial subjects and is the Editor of the Venture Capital Manual
published by Warren, Gorham and Lamont. Mr. Lee received an BA from
Lehigh University, an MBA from the Wharton School of Finance and
Commerce at the University of Pennsylvania, and a Juris Doctor degree
from Fordham University School of Law. He is a member of the
Massachusetts and New York State Bar Associations. Mr. Lee is the Flavin
Visiting Professor of Entrepreneurship at the University of
Massachusetts at Amherst. Profile
on PolyMedica?
Mr. Lee: PolyMedica Corporation is a public company that is rapidly
growing and is the leading national
